Status: Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults
The goal of this clinical trial is to learn which dose of study drug IBIO-600 has the right balance of safety, tolerability and impact on body composition in overweight and obese adult participants.
Participants needed: 32
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: iBio, Inc.Updated: May 29, 2026Locations: 1
Eligibility criteria
Aged 18 to 65 years of age [+8]
An underlying physical or psychological medical conditions that, in the opinion... [+8]